From: Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Anchor drug at enrolment
Anchor drug at 48 weeks
NNRTIs
PIs
INSTI
Total
NVP
EFV
LPV
ATV
122
6
3
1
0
132
115
7
126
28
30
56
2
123
34
65
346